Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Jul;17(4):237-9.
doi: 10.4103/0972-5229.118443.

Acute arterial thrombosis associated with inadvertent high dose of tranexamic acid

Surjya Prasad Upadhyay  1 , Piyush N Mallick, Manish Jagia, Raj Kumar A Singh
Affiliations
Case Reports

Acute arterial thrombosis associated with inadvertent high dose of tranexamic acid

Surjya Prasad Upadhyay et al. Indian J Crit Care Med. 2013 Jul.

Abstract

Tranexamic acid (TA) act as anti-fibrinolytic agent and is widely used to limit bleeding in clinical practice. Tranexemic acid bind with plasminogen and prevent its conversion to plasmin, which limits the fibrinolytic pathway, so there is a theoretical risk of increasing thrombosis with high or prolonged therapy with TA. We encountered a case of acute arterial thrombosis following inadvertent administration of high dose of TA. A 27-years-old male with no other co-morbidity was ordered intravenous 1 gm TA to control excessive bleeding from previous bladder injury, but by mistake, he received 10 gm of TA. The patient developed signs and symptoms of acute ischemia in the right lower limb, which was diagnosed as acute iliac arterial thrombosis by computed tomography (CT) angiography. The patient was managed with systemic heparinization, fasciotomy for impending gangrene and other supportive care following which he recovered fully within a few days. Caution should be exercised for all prophylactic use, especially with high dosage or prolonged therapy with TA.

Keywords: Arterial thrombosis; hemorrhage control; thrombo-embolism; tranexamic acid.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CT angiography showing thrombosis of right common iliac artery and proximal femoral artery
See this image and copyright information in PMC

References

    1. CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage: A randomised, placebo controlled trial. The Lancet. 2010;376:23–32. - PubMed
    1. Dzik WH, Blajchman MA, Fergusson D, Hameed M, Henry B, Kirkpatrick AW, et al. Clinical review: Canadian National Advisory Committee on Blood and Blood Products: Massive Transfusion Consensus Conference 2011: Report of the panel. Critical Care. 2011;15:242. - PMC - PubMed
    1. Ramstrom G, Blomback M, Egberg N, Johnsson H, Ljungberg B, Schulman S. Oral surgery in patients with hereditary bleeding disorders. A survey of treatment in the Stockholm area (1974-1985) Int J Oral Maxillofac Surg. 1989;18:320–2. - PubMed
    1. Endo Y, Nishimura S, Miura A. Deep-vein thrombosis induced by tranexamic acid in idiopathic thrombocytopenic purpura [letter] JAMA. 1988;259:3561–2. - PubMed
    1. Woo KS, Tse LK, Woo JL. Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy. Br J Clin Pract. 1989;43:465–6. - PubMed

Publication types

LinkOut - more resources